Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease
- PMID: 17849313
- DOI: 10.1080/13550280701422383
Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease
Abstract
Among the many variables affecting transmission and pathogenesis of the human immunodeficiency virus type 1(HIV-1), the effects of HIV subtypes, or clades, on disease progression remain unclear. Although debated, some studies have found that the variable env and pol sequences of different subtypes of HIV-1 may endow some subtypes with greater degrees of cell tropism, virulence, and drug resistance, which may lead to differences in overall disease progression. HIV-associated dementia (HAD) appears to be associated with viral diversity and markers of immune activation. Africa has the highest prevalence of HIV, largest viral diversity, and is where clade recombination occurs most frequently. All of these factors would suggest that HAD would pose the largest threat in this region of the world. Although investigations into the effects of different subtypes on overall disease progression are well documented, few have looked into the effects of subtypes on neurological disease progression. This review highlights the need for more international research involving the neurological effects and especially the clinical presentation of dementia for the entire range of the group M HIV-1 subtypes.
Similar articles
-
HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda.Clin Infect Dis. 2009 Sep 1;49(5):780-6. doi: 10.1086/605284. Clin Infect Dis. 2009. PMID: 19622045 Free PMC article.
-
Diversity of human immunodeficiency virus type 1 subtypes in Kagera and Kilimanjaro regions, Tanzania.AIDS Res Hum Retroviruses. 2008 Jun;24(6):761-9. doi: 10.1089/aid.2007.0311. AIDS Res Hum Retroviruses. 2008. PMID: 18507522
-
Human immunodeficiency virus type 1 clade A and D neurotropism: molecular evolution, recombination, and coreceptor use.Virology. 2001 Apr 25;283(1):19-30. doi: 10.1006/viro.2001.0876. Virology. 2001. PMID: 11312658
-
[Variability of human immunodeficiency virus type 1].Bull Soc Pathol Exot. 1999 Sep-Oct;92(4):261-3. Bull Soc Pathol Exot. 1999. PMID: 10572662 Review. French.
-
Differential Contribution of HIV-1 Subtypes B and C to Neurological Disorders: Mechanisms and Possible Treatments.AIDS Rev. 2019;21(2):76-83. doi: 10.24875/AIDSRev.19000051. AIDS Rev. 2019. PMID: 31332398 Free PMC article. Review.
Cited by
-
Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND.Cell Mol Life Sci. 2020 Dec;77(24):5079-5099. doi: 10.1007/s00018-020-03561-4. Epub 2020 Jun 23. Cell Mol Life Sci. 2020. PMID: 32577796 Free PMC article. Review.
-
HIV-1 nef protein structures associated with brain infection and dementia pathogenesis.PLoS One. 2011 Feb 9;6(2):e16659. doi: 10.1371/journal.pone.0016659. PLoS One. 2011. PMID: 21347424 Free PMC article.
-
Cerebrospinal fluid viral load and intrathecal immune activation in individuals infected with different HIV-1 genetic subtypes.PLoS One. 2008 Apr 16;3(4):e1971. doi: 10.1371/journal.pone.0001971. PLoS One. 2008. PMID: 18414666 Free PMC article.
-
Neruodevelopmental Outcomes in Preschool Children Living With HIV-1 Subtypes A and D in Uganda.Pediatr Infect Dis J. 2018 Dec;37(12):e298-e303. doi: 10.1097/INF.0000000000002097. Pediatr Infect Dis J. 2018. PMID: 29746376 Free PMC article. Clinical Trial.
-
Second assessment of NeuroAIDS in Africa.J Neurovirol. 2008 Apr;14(2):87-101. doi: 10.1080/13550280701829793. J Neurovirol. 2008. PMID: 18370346 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources